Hemedex, Inc.
Hemedex, Inc., was founded in 2000 to commercialize a proprietary platform technology conceived at the Massachusetts Institute of Technology to quantify tissue perfusion (i.e., blood flow at the capillary level). This technology addresses the need for real-time prognostic data in complex medical and surgical procedures. These complex procedures often involve compromised vasculature, delayed ischemia, or other serious pathophysiology, resulting in high rates of morbidity, delayed recuperation, poor patient outcome, and higher overall costs. Hemedex’s patented technology can provide an early warning of impending tissue ischemia, help target appropriate therapies, and rapidly assess the effect of interventions on cerebral blood flow (CBF), thus providing clinicians with a powerful tool to enhance patient care. All Hemedex products are FDA cleared. The Cranial Bolt Kit product line and the QFlow 500 Perfusion Probe are CE Marked.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Nationally (across the country)
- Year Founded:
- 2000
About Us
Reveal The Unknown...
Know The Flow™
Hemedex provides a complete solution for continuous, real-time measurement of cerebral perfusion in absolute units by offering the Bowman Perfusion Monitor, perfusion probe, titanium bolts, and cranial drill bits.
Our Vision
To improve patient outcomes and reduce healthcare costs by providing insight for therapy
Our Mission
To elevate standards of care by delivering the most trusted and widely used tissue perfusion measurement devices available